Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Research and development	$ 1,693	$ 434	$ 2,962	$ 1,363
General and administrative	531	495	1,725	1,782
Total operating expenses	2,224	929	4,687	3,145
Operating loss	2,224	929	4,687	3,145
Other expenses		1		1
Finance expenses (income), net	(1)	(2)	(2)	2
Net Loss	2,223	928	4,685	3,148
Other comprehensive income:
Foreign currency translation adjustment	(6)	(1)	(17)	(36)
Comprehensive loss for the period	$ 2,217	$ 929	$ 4,668	$ 3,112
Basic net loss per common stock	$ (0.10)	$ (0.06)	$ (0.28)	$ (0.20)
Diluted net loss per common stock	$ (0.10)	$ (0.06)	$ (0.28)	$ (0.20)
Weighted average number of common stock outstanding used in computing basic net loss per share	22,968,663	15,473,521	20,032,634	15,468,279
Weighted average number of common stock outstanding used in computing diluted net loss per share	22,968,663	15,473,521	20,032,634	15,468,279